Blocking two-component signalling enhances Candida albicans virulence and reveals adaptive mechanisms that counteract sustained SAPK activation
| dc.contributor.author | Day, Alison M | |
| dc.contributor.author | Smith, Deborah A | |
| dc.contributor.author | Ikeh, Mélanie A C | |
| dc.contributor.author | Haider, Mohammed | |
| dc.contributor.author | Herrero De Dios, Carmen M | |
| dc.contributor.author | Brown, Alistair J P | |
| dc.contributor.author | Morgan, Brian A | |
| dc.contributor.author | Erwig, Lars P | |
| dc.contributor.author | MacCallum, Donna M | |
| dc.contributor.author | Quinn, Janet | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.University of Aberdeen | en |
| dc.contributor.institution | University of Aberdeen.MRC Centre for Medical Mycology | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2017-03-20T10:28:26Z | |
| dc.date.available | 2017-03-20T10:28:26Z | |
| dc.date.issued | 2017-01 | |
| dc.description | This work was funded by the UK Biotechnology and Biological Research Council [www.bbsrc.ac.uk] JQ (BB/K016393/1); AJPB (BB/K017365/1). The work was also supported by the Wellcome Trust [www.wellcome.ac.uk], JQ (086048, 097377); AJPB (097377)); LPE (097377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 27 | |
| dc.format.extent | 3321730 | |
| dc.identifier | 85606967 | |
| dc.identifier | 6b06d929-b887-4a8e-95a2-a55b8472aeb9 | |
| dc.identifier | 85010977522 | |
| dc.identifier.citation | Day, A M, Smith, D A, Ikeh, M A C, Haider, M, Herrero De Dios, C M, Brown, A J P, Morgan, B A, Erwig, L P, MacCallum, D M & Quinn, J 2017, 'Blocking two-component signalling enhances Candida albicans virulence and reveals adaptive mechanisms that counteract sustained SAPK activation', PLoS Pathogens, vol. 13, no. 1, e1006131, pp. 1-27. https://doi.org/10.1371/journal.ppat.1006131 | en |
| dc.identifier.doi | 10.1371/journal.ppat.1006131 | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 1553-7366 | |
| dc.identifier.other | ORCID: /0000-0003-4833-0378/work/47631117 | |
| dc.identifier.uri | http://hdl.handle.net/2164/8356 | |
| dc.identifier.vol | 13 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | PLoS Pathogens | en |
| dc.subject | R Medicine | en |
| dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
| dc.subject | BB/K016393/1 | en |
| dc.subject | BB/K017365/1 | en |
| dc.subject | Wellcome Trust | en |
| dc.subject | 086048 | en |
| dc.subject | 097377 | en |
| dc.subject.lcc | R | en |
| dc.title | Blocking two-component signalling enhances Candida albicans virulence and reveals adaptive mechanisms that counteract sustained SAPK activation | en |
| dc.type | Journal article | en |
